Health Quest Radiation Oncology Selects RayStation®


Health Quest Radiation Oncology Selects RayStation®

RaySearch Laboratories AB has received an order for its RayStation®
treatment planning system from Health Quest Systems, Inc., headquartered
in LaGrange, New York.

Health Quest's radiation oncology enterprise comprises the departments
of four community locations that have been serving regional patients in
New York's Mid-Hudson Valley since 1887. They are; Dyson Cancer Center
at Vassar Brothers Medical Center in Poughkeepsie, Ulster Radiation
Oncology Center in Kingston, a joint venture with Benedictine Hospital,
Fishkill Radiation Oncology in Fishkill and Wagner Cancer Pavilion at
Putnam Hospital Center in Carmel, respectively. Health Quest Systems has
established centers of excellence in these communities and pride
themselves in using the most advanced equipment for detection and
treatment in the fight against cancer.

Health Quest will use RayStation® as its treatment planning system for
advanced treatments, such as IMRT, and will be serving the four
treatment centers with a central patient database and thin client access
throughout the departments. Health Quest will systematically replace
their current treatment planning system with RayStation® for all
external beam treatment planning over a phased transition period.

The order also includes multi-criteria optimization which is an advanced
product enabling a more efficient treatment planning process. This
highly intuitive tool lets the clinician evaluate the impact of changing
different treatment priorities in real-time, which has a large potential
to speed up the time-consuming treatment planning optimization process.

Health Quest Systems Senior Medical Physicist, George Sherouse says: “I
have been privileged in my career to be present at the launch of several
game-changing innovations in radiation oncology treatment planning. As
the first totally new commercial platform in some time, designed and
built by an established industry leading software house, RayStation®
promises to be another game-changer. The rate at which RaySearch is able
to deliver innovations in clinical software is remarkable to me. I'm
thrilled to have the opportunity to lead an early adopter team at Health
Quest.”

Marc Mlyn, President of RaySearch Americas says: “We are delighted to
have the opportunity to work with Chief Physicist Dan Pavord and George
Sherouse. Both have been very active in the medical physics community,
and we look forward to implementing our second largest installation to
date with them leading the project for Health Quest.”

Johan Löf, CEO of RaySearch Laboratories AB says: “Community cancer
centers are very important and key to our overall strategic direction
for RayStation® in North America. RayStation® provides effective tools
for all aspects of radiation treatment planning and that is something
that Health Quest Systems recognized from the beginning. I am also
pleased to note that total order value of the three orders generated by
RaySearch Americas during August now surpasses one million US Dollars.”

About RayStation®
RayStation® integrates all RaySearch's advanced treatment planning
solutions into a flexible treatment planning system. It combines unique
features such as multi-criteria optimization tools with full support for
4D adaptive radiation therapy. It also includes functionality such as
RaySearch's market-leading algorithms for IMRT and VMAT optimization and
highly accurate dose engines for both photon and proton therapy. The
system is built on the latest software architecture and has a graphical
user interface offering state-of-the-art usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch's products are mainly sold through license agreements with
leading partners such as Philips, Nucletron, IBA Dosimetry, Varian,
TomoTherapy and Siemens. To date, 15 products have been launched through
partners and RaySearch's software is used at some 1,800 clinics in more
than 30 countries. In addition, RaySearch offers the proprietary
treatment planning system RayStation® directly to clinics. RaySearch was
founded in 2000 as a spin-off from Karolinska Institutet in Stockholm
and the company is listed in the Small Cap segment on NASDAQ OMX
Stockholm.

For more information about RaySearch, visit
www.raysearchlabs.com (http://www.raysearchlabs.com/).

 
For further information, contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com (johan.lof@raysearchlabs.com)

Attachments